Supplement, Infant Formula Acceptable Claims Not Equivalent – NCL
This article was originally published in The Tan Sheet
Executive Summary
Claims approved for dietary supplements containing DHA may not be suitable for DHA- and ARA-fortified infant formulas, the National Consumers League says in a Feb. 5 letter to the National Advertising Division of the Council of Better Business Bureaus
You may also be interested in...
Mead DHA/ARA-Fortified Infant Formula Slated For February Release
Mead Johnson Nutritionals' Enfamil LIPIL, an infant formula fortified with ARA and DHA fatty acid oils, will be priced in the U.S. at a 10%-15% premium to the line's Enfamil with Iron product, the firm said
Neuromins DHA Claims Not Supported By Infant Formula Data, NAD Finds
Data showing DHA-fortified infant formulas help improve babies' cognitive development are not adequate to substantiate similar claims made for DHA-containing dietary supplements taken by pregnant or nursing mothers, NAD states in its June Case Reports.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC